Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 05, 2026
HSBC Holdings (HSBC) Delivers +60% Profit Surge in Q2 2026

HSBC Holdings (HSBC) Delivers +60% Profit Surge in Q2 2026

Key Takeaways

  • HSBC reported second-quarter profit before tax of $10.1 billion, a 60% year-over-year surge that comfortably beat the consensus estimate of $9.51 billion.
  • Revenue climbed to $19.1 billion, exceeding analyst forecasts of $18.51 billion, driven by strong wealth management fees and higher net interest income.
  • The bank resumed share buybacks with a $1 billion repurchase program, its first since pausing in October 2025 following the Hang Seng Bank privatization.
  • First-half annualized return on average tangible equity (RoTE) reached 19.1%, well above the bank's full-year target of 17% or better.
  • Full-year banking net interest income (NII) guidance was raised to "at least $46 billion," reflecting an improved interest rate outlook.
  • A second interim dividend of $0.10 per share was approved, underscoring confidence in the bank's capital generation.

Putting the Results in Context

HSBC Holdings' second-quarter and first-half 2026 results, released on August 4, 2026, arrive at a pivotal moment for the London-headquartered global banking giant. The bank is navigating a complex macroeconomic environment shaped by geopolitical tensions in the Middle East, evolving US-China trade dynamics, and shifting interest rate expectations. This earnings report serves as the first major checkpoint since HSBC outlined ambitious medium-term targets in February 2026, including a RoTE of 17% or better through 2028. With the bank's restructuring efforts under Group CEO Georges Elhedery gaining momentum, investors were closely watching whether the simplified four-business structure could deliver consistent growth across all segments while maintaining cost discipline and capital strength. I also checked this using Tickeron’s AI Screener to see how HSBC stacks up against peers in the sector.

Reported Results

HSBC delivered broad-based strength across its global franchise in the second quarter of 2026. Reported profit before tax jumped 60% year-over-year to $10.1 billion, surpassing the analyst consensus of $9.51 billion. The comparison benefited from a favorable swing in notable items — the prior-year quarter included a $2.1 billion charge related to the bank's stake in China's Bank of Communications. Even excluding notable items and currency effects, pre-tax profit rose to $20.4 billion for the first half, up 6% from the same period in 2025.

Revenue for the quarter reached $19.1 billion ($19.12 billion on an adjusted basis), exceeding the $18.51 billion consensus estimate by approximately 3.3%. For the first half, revenue grew 11% year-over-year to $37.7 billion. Banking net interest income (NII), which reflects interest earned on loans minus interest paid on deposits, rose 8% to $22.9 billion in the first half, supported by deposit balance growth and the reinvestment of the bank's structural hedge at higher yields. Net interest margin (NIM), a key measure of lending profitability, improved to 1.61% from 1.57% a year earlier.

Wealth management was a standout performer, with fee and other income in the bank's International Wealth and Premier Banking (IWPB) division growing 21% in the second quarter. Wealth balances reached $1.1 trillion, cementing HSBC's position as the leading wealth manager in Asia. Wholesale transaction banking also posted strong fee growth, supported by higher customer activity, particularly in Hong Kong.

Expected credit losses (ECL), the amount banks set aside for potential loan defaults, totaled $2.4 billion for the first half, up from $2.2 billion a year earlier. The increase reflected charges related to a UK fraud exposure, Hong Kong commercial real estate, and uncertainty linked to the Middle East conflict. On a positive note, the bank's capital position remained robust, with a common equity tier 1 (CET1) ratio — a core measure of financial strength — of 14.1%, within the medium-term target range of 14% to 14.5%. From what I see, the underlying trends here look solid when viewed through the lens of Tickeron’s AI Trend Prediction Engine.

Market Reaction and Investor Sentiment

Despite the strong headline numbers, HSBC's stock reaction was notably muted. Shares slipped 0.37% to $107.46 in early trading on August 4, following a previous close of $107.86, with the Hong Kong-listed shares also trading slightly lower. The subdued price action suggests that much of the positive earnings momentum had already been priced in — the stock had surged approximately 36% year-to-date in Hong Kong, building on a 61% gain in 2025, and was trading near its 52-week high.

Investor sentiment entering the report was broadly optimistic, buoyed by the bank's restructuring progress, easing fears around US-China trade tensions, and consistent execution across all four business units. The resumption of buybacks was a welcome development after a nine-month pause, signaling management's confidence in the capital position. However, the uptick in expected credit losses and ongoing geopolitical uncertainty may temper near-term enthusiasm. The market also appeared to take a measured view of the fact that a significant portion of the profit jump was attributable to the absence of last year's Bank of Communications impairment, rather than purely organic growth.

Forward Outlook and Key Factors to Monitor

HSBC enters the second half of 2026 with strengthened momentum, but investors should watch several key factors that will shape the bank's trajectory through year-end.

Interest Rate Trajectory and NII Sensitivity: The upgrade to full-year banking NII guidance — now "at least $46 billion" versus "around $46 billion" previously — reflects a more favorable rate environment. However, interest rate expectations remain volatile and market-dependent. Any significant shift in central bank policy, particularly from the Federal Reserve or the Bank of England, could impact HSBC's NII and net interest margin in the quarters ahead. The bank's large deposit base and structural hedge provide some insulation, but rate sensitivity remains a critical variable.

Credit Quality and Asset Risks: The rise in ECL charges to an annualized 47 basis points of gross loans in the first half, slightly above the full-year guidance of approximately 45 basis points, warrants close monitoring. Key areas of concern include the Hong Kong commercial real estate sector, where stage 3 charges persisted in Q2, and the broader impact of the Middle East conflict on loan portfolios. Any further deterioration in credit metrics could pressure profitability and investor sentiment.

Wealth Management Growth Trajectory: The wealth division's 21% fee income growth in Q2 underscores the potential of HSBC's Asian wealth franchise. With $1.1 trillion in wealth balances and $64 billion in net new money during the first half, the division is emerging as a powerful earnings engine. Sustaining this momentum will depend on continued customer activity in Hong Kong and mainland China, as well as broader market conditions that influence asset valuations and transaction volumes.

Cost Discipline and Restructuring Progress: HSBC continues to target operating expense growth of approximately 1% for 2026, with organizational simplification savings helping offset inflationary pressures and technology investments. The ability to deliver on this commitment while funding growth initiatives will be a key test of management's execution capabilities. Cost efficiency improvements have already lowered the cost efficiency ratio to 46.2% from 49.9% in the prior-year period, and further progress will support the RoTE target.

Capital Return and Buyback Execution: The $1 billion buyback resumption is a positive signal, but the pace and scale of future capital returns will depend on the CET1 ratio remaining within the 14% to 14.5% target range. With strong capital generation of 190 basis points in the first half, the bank appears well-positioned to sustain shareholder distributions, though regulatory developments and risk-weighted asset growth could influence the cadence of buybacks in subsequent quarters.

Enhancing Research with Tickeron Tools

In my own analysis workflow, I frequently turn to Tickeron’s AI Screener to quickly filter for similar earnings-driven opportunities across global banks and compare key metrics like RoTE, NII growth, and credit trends. It helps surface ideas efficiently without replacing my own judgment, and I’ve found it particularly useful when cross-checking sector performance after reports like this one from HSBC.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: HSBC

HSBC in -1.32% downward trend, falling for three consecutive days on July 29, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where HSBC declined for three days, in of 219 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for HSBC moved out of overbought territory on August 04, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 51 similar instances where the indicator moved out of overbought territory. In of the 51 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 21 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

HSBC broke above its upper Bollinger Band on July 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HSBC advanced for three days, in of 366 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 419 cases where HSBC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 20, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HSBC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.849) is normal, around the industry mean (1.938). P/E Ratio (15.149) is within average values for comparable stocks, (16.226). Projected Growth (PEG Ratio) (1.054) is also within normal values, averaging (1.631). HSBC has a moderately high Dividend Yield (0.035) as compared to the industry average of (0.025). P/S Ratio (4.968) is also within normal values, averaging (4.327).

Notable companies

The most notable companies in this group are JPMorgan Chase & Co (NYSE:JPM), Bank of America Corp (NYSE:BAC), HSBC Holdings PLC (NYSE:HSBC), Wells Fargo & Co (NYSE:WFC), Citigroup (NYSE:C), Barclays PLC (NYSE:BCS).

Industry description

Major banks are among the biggest companies in the world, often times with global reach and market capitalizations in the multi-billions. Large banks often have multiple arms spanning different disciplines, from deposits, to investment banking, to wealth management and insurance. The biggest banks often have key competitive advantages over smaller players in the industry in terms of brand recognition, cost of capital, and efficiency. Think J.P. Morgan, Bank of America, Wells Fargo, and Citigroup.

Market Cap

The average market capitalization across the Major Banks Industry is 216.86B. The market cap for tickers in the group ranges from 1.04M to 950.36B. JPM holds the highest valuation in this group at 950.36B. The lowest valued company is BACRP at 1.04M.

High and low price notable news

The average weekly price growth across all stocks in the Major Banks Industry was 1%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 20%. ING experienced the highest price growth at 6%, while SMFG experienced the biggest fall at -3%.

Volume

The average weekly volume growth across all stocks in the Major Banks Industry was 3%. For the same stocks of the Industry, the average monthly volume growth was 3% and the average quarterly volume growth was -35%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 67
P/E Growth Rating: 30
Price Growth Rating: 39
SMR Rating: 8
Profit Risk Rating: 19
Seasonality Score: -22 (-100 ... +100)
View a ticker or compare two or three
HSBC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a major bank

Industry MajorBanks

Profile
Details
Industry
Major Banks
Address
8 Canada Square
Phone
+44 2079918888
Employees
221000
Web
https://www.hsbc.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.